Medicaid Alternative Payment Models for Prescription Drugs: Do They Add Value for States?
Wednesday, Dec. 12, 2018
2-3 pm (EST)
Listen to the Webinar.
Download the Slides.
As states struggle with the increasing cost of prescription drugs, they are testing various alternative payment models (APMs). The Oklahoma Health Care Authority is a national leader with four alternative payment models in the form of direct contracts with pharmaceutical manufacturers. These contracts are each based on a specific drug, agreed-upon outcomes, and approaches to measurement. Speakers included:
- Burl Beasley, BS Pharm, MPH, MS Pharm, Director, Pharmacy Services, Medicaid Operations Division, Oklahoma Health Care Authority
- Terry Cothran, DPh, Director, University of Oklahoma College of Pharmacy, Pharmacy Management Consultants
- Russell Knoth, MA, PhD, Director, Health Economics and Outcomes, Eisai
Listen to the related, May 9, 2019, webinar Medicaid Alternative Payment Models for Prescription Drugs: A Look at Three States here.
For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 
